[Effects of treatment with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride in oral adminstration on bronchial secretions; cytological findings].
D000814:Aniline Compounds / Q000627:therapeutic use*; D000996:Antitussive Agents / Q000627:therapeutic use*; D001987:Bronchiectasis / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D005100:Expectorants / Q000627:therapeutic use*; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000188:drug therapy*; D011009:Pneumoconiosis / Q000188:drug therapy; D011656:Pulmonary Emphysema / Q000188:drug therapy; D014050:Toluene / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000814:Aniline Compounds; D000996:Antitussive Agents; D005100:Expectorants; D014050:Toluene
Effetti del trattamento con N-cicloesil-N-metil-(2-amino-3,5-dibromobenzil)-ammonio cloruro per via orale sulle secrezioni bronchiali: rilievi citologici.